Ebola Virus Disease | PharmaShots

Merck’s Ervebo [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Receives EC’s Conditional Approval to Prevent Ebola Virus Disease

November 12, 2019November 12, 2019Tuba Khan

Shots: The EC has granted conditional marketing authorization to Ervebo for active immunization of individuals aged ≥ 18yrs. to protect against Ebola virus [Read More...]

Janssens Reports Results of Tremfya (guselkumab) in Two P-III DISCOVER Studies for Psoriatic Arthritis

Janssen Reports Submission of MAA to EMA for its Investigational Ebola Vaccine Regimen to Prevent Ebola Virus Disease

November 8, 2019November 8, 2019Tuba Khan

Shots: Janssen has submitted MAA to EMA for an investigational Ebola vaccine regimen in two doses Ad26.ZEBOV, MVA-BN-Filo for the prevention of Ebola [Read More...]

Merck’s V920 Ebola Zaire Vaccine Receives CHMP Positive Opinion to Protect Against Ebola Virus Disease

October 18, 2019October 18, 2019Shiwani Sharma

Shots: The EMA’s CHMP has adopted the positive opinion recommending conditional marketing authorization for the V920 Ebola Zaire vaccine (rVSVΔG-ZEBOV-GP, live), indicated for [Read More...]